Eversept Partners’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-59,639
Closed -$519K 86
2022
Q1
$519K Buy
+59,639
New +$519K 0.04% 64